Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

Nurse-Led Care Efficacious, Cost-Effective for Gout

More patients receiving nurse-led care had serum urate concentrations less than 360 µmol/L at 2 years

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

MONDAY, Oct. 29, 2018 (HealthDay News) -- For patients with gout, nurse-led care is efficacious and cost-effective compared with usual care led by general practitioners (GPs), according to a study published Oct. 20 in The Lancet.

Michael Doherty, M.D., from the University of Nottingham in the United Kingdom, and colleagues randomly assigned 517 adults who had experienced a gout flare in the last 12 months to receive nurse-led care (255 patients), which included provision of individualized information and engaging patients in shared decision making, or to continue with GP-led usual care (262 patients). Patients were assessed at baseline and after one and two years.

The researchers found high uptake of and adherence to urate-lowering therapy in association with nurse-led care. Compared with those receiving usual care, more patients receiving nurse-led care had serum urate concentrations less than 360 µmol/L at two years (95 versus 30 percent; risk ratio, 3.18). All secondary outcomes favored the nurse-led group at two years. Per quality-adjusted life year gained, the cost for the nurse-led intervention was £5,066 at two years.

"Although nurses delivered this care, the principles of patient education, treat-to-target urate-lowering strategy, and regular follow-up and monitoring are applicable to any health professional who treats people with gout. Although this takes more time with the patient to start with, long-term this becomes very cost-effective," Doherty said in a statement.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text
Editorial

Last Updated: